Harrigan, P. R., Kinghorn, I., Bloor, S., Kemp, S. D., Nájera, I., Kohli, A., & Larder, B. A. (1996). Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.

Harrigan, P R., I. Kinghorn, S. Bloor, S D. Kemp, I. Nájera, A. Kohli, a B A. Larder. Significance of Amino Acid Variation At Human Immunodeficiency Virus Type 1 Reverse Transcriptase Residue 210 for Zidovudine Susceptibility. 1996.

Harrigan, P R., et al. Significance of Amino Acid Variation At Human Immunodeficiency Virus Type 1 Reverse Transcriptase Residue 210 for Zidovudine Susceptibility. 1996.